# Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults

> **NCT05824091** · PHASE1 · COMPLETED · sponsor: **Gates Medical Research Institute** · enrollment: 119 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** MK-7762 (TBD09)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05824091
- **Lead sponsor:** Gates Medical Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-23
- **Primary completion:** 2024-03-26
- **Final completion:** 2024-03-26
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2024-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05824091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05824091, "Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05824091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*